Skip to main content
. 2020 Jan 9;19(3):1842–1848. doi: 10.3892/ol.2020.11274

Figure 2.

Figure 2.

Relationship between MAPK and EGFR expression and survival rate in TNBC. Kaplan-Meier analysis was used for survival analysis and the log-rank test was used to analyze the differences in survival rate. Survival of patients with and without (A) MAPK and/or (B) EGFR expression. MAPK, mitogen-activated protein kinase; EGFR epidermal growth factor receptor; TNBC, triple negative breast cancer.